Search

Open Menu Hide Menu Why Work Here Military & Veterans Culture & Values Locations Life in Dallas Departments Advanced Practice Providers Adult Pediatrics Allied Health Faculty Imaging Services Information Technology Nursing Pharmacy Professional Services Research Residencies & Fellowships Benefits Job Search Join Talent Community Log In Talent Community Sign In Current Employees Previous Applicants News Get to know what’s happening here Search Jobs Begin typing to find suggestions. Category

Zhijian ‘James’ Chen, Ph.D., honored with Lasker Award and Paul Ehrlich Prize Congratulations to Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research, on being named the recipient of this year’s Albert Lasker Basic Medical Research Award, regarded as the country’s preeminent biomedical research prize. Dr. Chen was recognized for his discovery of the cGAS enzyme, which senses invading pathogens and triggers the body’s innate immune

Filter by Specialty All Big Data, Informatics Cardiac, Pulmonary Digestive, Liver Emergency, General Medicine Endocrine, Exocrine, Metabolism Hematology, Oncology, Immunology, Infection Nervous and Musculoskeletal Systems Organizational Management Pediatrics Urogenital, Reproductive Systems Last Name All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z … loading Back-to top

9/22/25, 9:47 AM Page 1 of 1https://outlook.office.com/mail/inbox/id/AAQkAGU5YzExMDA2LWF…EtNDk0OS04YzhhLWE0YTNlOGQ4MzEzNAAQAP3loQEcn7FDjDt9WW5FvTA%3D Outlook The UTSW Insider | Wednesday, Sept. 17, 2025 From UTSW Insider <utswinsider@utsouthwestern.edu> Date Wed 9/17/2025 7:01 AM To John Maxwell <John.Maxwell@UTSouthwestern.edu> A message from your SECC ambassador Hi friends! It’s Tia from the Simmons Cancer Center. I’m honored to be this year’s State Employee Charitable Campaign (SECC

Filter by Specialty All Big Data, Informatics Cardiac, Pulmonary Digestive, Liver Emergency, General Medicine Endocrine, Exocrine, Metabolism Hematology, Oncology, Immunology, Infection Nervous and Musculoskeletal Systems Organizational Management Pediatrics Urogenital, Reproductive Systems Last Name All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z … loading Back-to top

9/22/25, 9:48 AM Page 1 of 1https://outlook.office.com/mail/inbox/id/AAQkAGU5YzExMDA2LWF…tNDk0OS04YzhhLWE0YTNlOGQ4MzEzNAAQALLPw0Agph5Bs8UNjUFojW0%3D Outlook The UTSW Insider | Monday, Sept. 15, 2025 From UTSW Insider <utswinsider@utsouthwestern.edu> Date Mon 9/15/2025 7:03 AM To John Maxwell <John.Maxwell@UTSouthwestern.edu> Building on our commitment to our patients: Improving access to care in Fort Worth We are pleased to announce that UT Southwestern is advancing plans to offer

Discover Strategist and other Professional & Executive jobs in Dallas, TX and apply online today!

9/28/25, 4:04 PM Page 1 of 1https://outlook.office.com/mail/inbox/id/AAQkAGU5YzExMDA2LWF…tNDk0OS04YzhhLWE0YTNlOGQ4MzEzNAAQADUERGBHhOVHo7oolGyR94s%3D Outlook The UTSW Insider | Wednesday, Sept. 24, 2025 From UTSW Insider <utswinsider@utsouthwestern.edu> Date Wed 9/24/2025 7:15 AM To John Maxwell <John.Maxwell@UTSouthwestern.edu> Big ideas live here: Explore UTSW’s Innovation Hub The future of medicine isn’t just imagined – it’s built. At UT Southwestern, our new Innovation Hub is the engine

Open Menu Hide Menu Why Work Here Military & Veterans Culture & Values Locations Life in Dallas Departments Advanced Practice Providers Adult Pediatrics Allied Health Faculty Imaging Services Information Technology Nursing Pharmacy Professional Services Research Residencies & Fellowships Benefits Job Search Join Talent Community Log In Talent Community Sign In Current Employees Previous Applicants « All News Design and Manufacturing All in One Place March 11, 2015 / in News / by Symphony Talent

What to know about the updated COVID-19 vaccines With COVID-19 back in the news, there are a lot of questions about the most recent vaccines and who might need them. The new Pfizer and Moderna vaccines using mRNA technology are specifically designed to target the most widespread variants this year: JN.1, KP.1, KP.2, and KP.3. The Novavax vaccine is an alternative for people ages 12 and older who are allergic to a component in the mRNA vaccines. See the latest vaccine recommendations for